+3&2?WI54):<@>5RTY0+
SYSTEM PROCESSING...
+3&2?WI54):<@>5RTY0+
SYSTEM PROCESSING...
Posted: 2025-04-29 20:53:32 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-29 20:53:50 UTC
Verified By
Rollup News
Pfizer CEO Albert Bourla states that potential tariffs from the Trump administration on drug imports are causing uncertainty, leading the company to hold back on investments in U.S. facilities and research.
Economic impact of tariffs on pharmaceutical companies
Uncertainty in trade policy affecting investment decisions
Potential reduction in U.S. investments by Pfizer
Unpredictable tariff policies
Increased costs due to existing tariffs
Uncertainty affecting investment strategies